The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Adaptive Biotechnologies Corp (NASDAQ: ADPT) closed at $4.45 in the last session, up 10.42% from day before closing price of $4.03. In other words, the price has increased by $10.42 from its previous closing price. On the day, 2.45 million shares were traded. ADPT stock price reached its highest trading level at $4.55 during the session, while it also had its lowest trading level at $4.07.
Ratios:
We take a closer look at ADPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.35 and its Current Ratio is at 4.51. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.79.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 05 ’24 when ROBINS CHAD M sold 48,673 shares for $3.43 per share. The transaction valued at 167,007 led to the insider holds 2,576,701 shares of the business.
RUBINSTEIN JULIE sold 39,070 shares of ADPT for $135,764 on Mar 05 ’24. The President now owns 472,754 shares after completing the transaction at $3.47 per share. On Mar 05 ’24, another insider, BENZENO SHARON, who serves as the Chief Commercial Ofc Imm Med of the company, sold 29,390 shares for $3.44 each. As a result, the insider received 100,994 and left with 327,415 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 655787584 and an Enterprise Value of 574809024. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.76 while its Price-to-Book (P/B) ratio in mrq is 2.39. Its current Enterprise Value per Revenue stands at 3.294 whereas that against EBITDA is -3.358.
Stock Price History:
The Beta on a monthly basis for ADPT is 1.36, which has changed by -0.42580646 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, ADPT has reached a high of $8.51, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is 27.58%, while the 200-Day Moving Average is calculated to be 14.61%.
Shares Statistics:
According to the various share statistics, ADPT traded on average about 1.58M shares per day over the past 3-months and 1328480 shares per day over the past 10 days. A total of 145.08M shares are outstanding, with a floating share count of 142.26M. Insiders hold about 3.47% of the company’s shares, while institutions hold 98.33% stake in the company. Shares short for ADPT as of 1719532800 were 12137380 with a Short Ratio of 7.69, compared to 1717113600 on 13382837. Therefore, it implies a Short% of Shares Outstanding of 12137380 and a Short% of Float of 10.58.
